These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15070812)

  • 1. ATP downregulates P2X7 and inhibits osteoclast formation in RAW cells.
    Hiken JF; Steinberg TH
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C403-12. PubMed ID: 15070812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts.
    Korcok J; Raimundo LN; Ke HZ; Sims SM; Dixon SJ
    J Bone Miner Res; 2004 Apr; 19(4):642-51. PubMed ID: 15005852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro.
    Gartland A; Buckley KA; Bowler WB; Gallagher JA
    Calcif Tissue Int; 2003 Oct; 73(4):361-9. PubMed ID: 12874700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages.
    Hu Y; Fisette PL; Denlinger LC; Guadarrama AG; Sommer JA; Proctor RA; Bertics PJ
    J Biol Chem; 1998 Oct; 273(42):27170-5. PubMed ID: 9765236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells.
    Lemaire I; Falzoni S; Leduc N; Zhang B; Pellegatti P; Adinolfi E; Chiozzi P; Di Virgilio F
    J Immunol; 2006 Nov; 177(10):7257-65. PubMed ID: 17082644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration.
    Pellegatti P; Falzoni S; Donvito G; Lemaire I; Di Virgilio F
    FASEB J; 2011 Apr; 25(4):1264-74. PubMed ID: 21233486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels.
    Chakfe Y; Seguin R; Antel JP; Morissette C; Malo D; Henderson D; Séguéla P
    J Neurosci; 2002 Apr; 22(8):3061-9. PubMed ID: 11943809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cultured dorsal root ganglion neuron P2X receptors.
    Grubb BD; Evans RJ
    Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of P2X7 receptors in rat peritoneal cells.
    Chen YW; Donnelly-Roberts DL; Namovic MT; Gintant GA; Cox BF; Jarvis MF; Harris RR
    Inflamm Res; 2005 Mar; 54(3):119-26. PubMed ID: 15883745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca(2+)-dependent reduction of glutamate aspartate transporter GLAST expression in astrocytes by P2X(7) receptor-mediated phosphoinositide 3-kinase signaling.
    Liu YP; Yang CS; Chen MC; Sun SH; Tzeng SF
    J Neurochem; 2010 Apr; 113(1):213-27. PubMed ID: 20070863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
    Bharti AC; Takada Y; Aggarwal BB
    J Immunol; 2004 May; 172(10):5940-7. PubMed ID: 15128775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis.
    Park H; Jung YK; Park OJ; Lee YJ; Choi JY; Choi Y
    J Immunol; 2005 Dec; 175(11):7193-201. PubMed ID: 16301623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
    Khapli SM; Mangashetti LS; Yogesha SD; Wani MR
    J Immunol; 2003 Jul; 171(1):142-51. PubMed ID: 12816992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity.
    Ren W; Li XH; Chen BD; Wooley PH
    J Orthop Res; 2004 Jan; 22(1):21-9. PubMed ID: 14656655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion.
    Fairbairn IP; Stober CB; Kumararatne DS; Lammas DA
    J Immunol; 2001 Sep; 167(6):3300-7. PubMed ID: 11544318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand.
    Buckley KA; Hipskind RA; Gartland A; Bowler WB; Gallagher JA
    Bone; 2002 Nov; 31(5):582-90. PubMed ID: 12477572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-kappa B signaling pathways in murine RAW 264.7 macrophages.
    Aga M; Watters JJ; Pfeiffer ZA; Wiepz GJ; Sommer JA; Bertics PJ
    Am J Physiol Cell Physiol; 2004 Apr; 286(4):C923-30. PubMed ID: 14684387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The P2X7 receptor and Pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF.
    Lemaire I; Falzoni S; Zhang B; Pellegatti P; Di Virgilio F
    J Immunol; 2011 Oct; 187(7):3878-87. PubMed ID: 21865551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
    Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
    Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis.
    Ishii M; Iwai K; Koike M; Ohshima S; Kudo-Tanaka E; Ishii T; Mima T; Katada Y; Miyatake K; Uchiyama Y; Saeki Y
    J Bone Miner Res; 2006 Jun; 21(6):965-76. PubMed ID: 16753027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.